A New Therapeutic Option by Subcutaneous Recombinant Hirudin in Patients with Heparin-induced Thrombocytopenia Type II - A Pilot Study

Author: Huhle G.   Hoffmann U.   Hoffmann I.   Liebe V.   Harenberg J.F.   Heene D.L.  

Publisher: Elsevier

ISSN: 0049-3848

Source: Thrombosis Research, Vol.99, Iss.4, 2000-08, pp. : 325-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content